Clinical evaluation of psychotropic drugs principles and guidelines
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
New York
Raven Press
1994
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV010092232 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t| | ||
| 008 | 950314s1994 xx |||| 00||| eng d | ||
| 020 | |a 0781701430 |9 0-7817-0143-0 | ||
| 035 | |a (OCoLC)30437188 | ||
| 035 | |a (DE-599)BVBBV010092232 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 |a DE-29 |a DE-20 |a DE-19 |a DE-578 | ||
| 050 | 0 | |a RC483 | |
| 082 | 0 | |a 616.89/18 |2 20 | |
| 084 | |a XI 5800 |0 (DE-625)153018:12905 |2 rvk | ||
| 245 | 1 | 0 | |a Clinical evaluation of psychotropic drugs |b principles and guidelines |c in assoc. with the NIMH ... Ed. Robert F. Prien |
| 264 | 1 | |a New York |b Raven Press |c 1994 | |
| 300 | |a XXI, 728 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 7 | |a Klinische geneeskunde |2 gtt | |
| 650 | 7 | |a Psychofarmaca |2 gtt | |
| 650 | 4 | |a Clinical Trials as Topic | |
| 650 | 4 | |a Drug Evaluation |x methods | |
| 650 | 4 | |a Mental Disorders |x drug therapy | |
| 650 | 4 | |a Mental illness |x Chemotherapy |x Evaluation | |
| 650 | 4 | |a Mental illness |x Chemotherapy |x Research | |
| 650 | 4 | |a Psychotropic Drugs | |
| 650 | 4 | |a Psychotropic drugs |x Testing | |
| 650 | 0 | 7 | |a Evaluation |0 (DE-588)4071034-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Psychopharmakon |0 (DE-588)4047729-0 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Psychopharmakon |0 (DE-588)4047729-0 |D s |
| 689 | 0 | 1 | |a Evaluation |0 (DE-588)4071034-8 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Prien, Robert F. |e Sonstige |4 oth | |
| 710 | 2 | |a National Institute of Mental Health (USA) |e Sonstige |0 (DE-588)8555-8 |4 oth | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006698610&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-006698610 | |
Datensatz im Suchindex
| DE-BY-UBM_katkey | 1414770 |
|---|---|
| DE-BY-UBM_media_number | 99992960593 |
| DE-BY-UBR_call_number | 02/23.X0422 |
| DE-BY-UBR_katkey | 2143283 |
| DE-BY-UBR_location | 00 |
| DE-BY-UBR_media_number | 069005247644 |
| _version_ | 1823051055469953024 |
| adam_text | RV CLINICAL EVALUATION OF PSYCHOTROPIC DRUGS PRINCIPLES AND GUIDELINES
IN ASSOCIATION WITH THE NIMH AND THE ACNP EDITORS ROBERT F. PRIEN, PH.D.
CHIEF, CLINICAL TREATMENT BRANCH DIVISION OF CLINICAL AND TREATMENT
RESEARCH NATIONAL INSTITUTE OF MENTAL HEALTH ROCKVILLE, MARYLAND DONALD
S. ROBINSON, M.D. CONSULTANT MELBOURNE, FLORIDA SECTION EDITORS C. JAMES
KLETT, M.D. JEROME LEVINE, M.D. KARL RICKELS, M.D. NINA R. SCHOOLER,
PH.D. RAVEN PRESS JP NEW YORK CONTENTS CONTRIBUTING AUTHORS IX PREFACE
XIX ACKNOWLEDGMENTS XXI SECTION I. HISTORICAL PERSPECTIVES 1. HISTORY
AND ROLE OF GUIDELINES AND GUIDANCE FOR DRUG EVALUATION 1 JEROME LEVINE
2. DECISION PROCESSES IN ESTABLISHING THE EFFICACY AND SAFETY OF
PSYCHOTROPIC AGENTS 13 LOUIS LASAGNA SECTION II. GENERAL PRINCIPLES IN
THE EVALUATION OF PSYCHOTROPIC DRUGS 3. DESIGN ISSUES FOR THE CLINICAL
EVALUATION OF PSYCHOTROPIC DRUGS 29 EUGENE M. LASKA, DONALD F. KLEIN,
PHILIP W. LAVORI, JEROME LEVINE, AND DONALD S. ROBINSON 4.
CLASSIFICATION ISSUES IN PATIENT SELECTION AND DESCRIPTION 69 JEAN
ENDICOTT, GERRI E. SCHWARTZ, J. HILLARY LEE, AND HAROLD PINCUS 5.
ASSESSMENT AND MEASUREMENT OF CLINICAL CHANGE 85 A. JOHN RUSH, CHRISTINA
M. GULLION, ALLEN RASKIN, ROBERT KELLNER, AND JOHN J. BARTKO 6.
PHARMACOLOGIC CONSIDERATIONS 123 DAVID J, GREENBLATT, DARRELL R.
ABERNETHY, AND PHILIP CHAIKIN 7. STATISTICAL ISSUES FOR THE CLINICAL
EVALUATION OF PSYCHOTROPIC DRUGS 139 PHILIP W. LAVORI, EUGENE M. LASKA,
AND E. H. UHLENHUTH 8. CLINICAL TRIAL IMPLEMENTATION 161 RONALD
KARTZINEL, ALAN B. LISOOK, BARBARA RULLO, JOANNE B. SEVERE, AND BERT
SPILKER 9. PREMARKETING SAFETY EVALUATION OF PSYCHOTROPIC DRUGS 185
THOMAS P. LAUGHREN, JEROME LEVINE, JONATHAN G. LEVINE, AND W. LEIGH
THOMPSON 10. POST-MARKETING SURVEILLANCE OF DRUGS 217 LEO E. HOLLISTER,
JUDITH K. JONES, AND SEYMOUR FISHER V VJ CONTENTS 11. DOCUMENTING AND
REPORTING THE STUDY RESULTS OF A RANDOMIZED CLINICAL TRIAL (SPICY
MEATBALLS, NOT PABULUM) 237 DAVID J. KUPFER, HELENA C. KRAEMER, AND JOHN
J. BARTKO 12. ETHICAL AND LEGAL CONSIDERATIONS IN DRUG TRIALS 261 DON
GALLANT AND SUSAN L. KRINSKY SECTION III. SPECIFI C PATIENT GROUPS:
APPLICATION OF GENERAL METHODOLOGIC PRINCIPLES 13. EVALUATING DRUG
TREATMENTS OF DEPRESSIVE DISORDERS 281 GERALD L. KLERMAN, MYRNA M.
WEISSMAN, ELLEN FRANK, JAMES H. KOCSIS, JOHN C. MARKOWITZ, AND STUART
MONTGOMERY 14. EVALUATING PHARMACOLOGIC TREATMENTS FOR BIPOLAR DISORDER
327 ALAN J. GELENBERG, ELLEN FRANK, MARTIN B. KELLER, ROBERT F. PRIEN,
AND ROBERT M. POST 15. METHODS FOR CLINICAL EVALUATION OF PHARMACOLOGIC
TREATMENTS OF SCHIZOPHRENIA 345 JOHN M. KANE, NINA R. SCHOOLER, STEPHEN
R. MARDER, GEORGE M. SIMPSON, AND DANIEL E. CASEY 16. EVALUATING DRUG
TREATMENTS OF GENERALIZED ANXIETY DISORDER AND ADJUSTMENT DISORDERS WITH
ANXIOUS MOOD 373 KARL RICKELS, RUSSELL NOYES, JR., DONALD S. ROBINSON,
EDWARD SCHWEIZER, AND E. H. UHLENHUTH 17. EVALUATION OF PSYCHOTROPIC
DRUG TREATMENT OF PANIC-RELATED DISORDERS AND SOCIAL PHOBIA 411 DONALD
F. KLEIN, MICHAEL R. LIEBOWITZ, JACK M. GORMAN, AND CARL P. LEWIS 18.
OBSESSIVE-COMPULSIVE DISORDER 431 WAYNE K. GOODMAN, STEVEN A. RASMUSSEN,
EDNA B. FOA, AND LAWRENCE H. PRICE 19. METHODS FOR THE EVALUATION OF
PHARMACOLOGIC AGENTS IN THE TREATMENT OF COGNITIVE AND OTHER DEFICITS IN
DEMENTIA 467 SAMUEL GERSHON, STEVEN H. FERRIS, JOHN S. KENNEDY, NEIL M.
KURTZ, JOHN E. OVERALL, BRUCE G. POLLOCK, BARRY REISBERG, AND PETER J.
WHITEHOUSE 20. CLINICAL TRIALS IN CHILDREN AND ADOLESCENTS 501 RACHEL G.
KLEIN, HOWARD ABIKOFF, RUSSELL A. BARKLEY, MAGDA CAMPBELL, JAMES F.
LECKMAN, NEAL D. RYAN, MARY V. SOLANTO, AND CAROL K. WHALEN 21.
EVALUATION OF PHARMACOLOGIC TREATMENTS IN EATING DISORDERS 547 KATHERINE
A. HALMI, W. STEWART AGRAS, WALTER H. KAYE, AND B. TIMOTHY WALSH
CONTENTS VII 22. EVALUATION OF HYPNOTIC MEDICATIONS 579 THOMAS ROTH,
TIMOTHY A. ROEHRS, GERALD W. VOGEL, AND WILLIAM C. DEMENT 23.
ESTABLISHING THE EFFICACY AND SAFETY OF MEDICATIONS FOR THE TREATMENT OF
DRUG DEPENDENCE AND ABUSE: METHODOLOGIC ISSUES 593 JACK D. BLAINE,
WALTER LING, THOMAS R. KOSTEN, CHARLES P. O BRIEN, AND ROBERT J.
CHIARELLO 24. EVALUATION OF PHARMACOLOGIC TREATMENTS FOR ALCOHOL ABUSE,
DEPENDENCE, AND THEIR COMPLICATIONS 625 MARKKU LINNOILA, JAN FAWCETT,
RICHARD K. FULLER, THOMAS C. HARFORD, PETER B. MARTIN, ROGER E. MEYER,
MYROSLAVA K. ROMACH, AND EDWARD M. SELLERS 25. EVALUATION OF
PHARMACOLOGIC TREATMENTS IN PERSONALITY DISORDERS 651 PAUL H. SOLOFF,
LARRY SIEVER, REX COWDRY, AND JAMES H. KOCSIS SUBJECT INDEX 675
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV010092232 |
| callnumber-first | R - Medicine |
| callnumber-label | RC483 |
| callnumber-raw | RC483 |
| callnumber-search | RC483 |
| callnumber-sort | RC 3483 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | XI 5800 |
| ctrlnum | (OCoLC)30437188 (DE-599)BVBBV010092232 |
| dewey-full | 616.89/18 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.89/18 |
| dewey-search | 616.89/18 |
| dewey-sort | 3616.89 218 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01873nam a2200481 c 4500</leader><controlfield tag="001">BV010092232</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">950314s1994 xx |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0781701430</subfield><subfield code="9">0-7817-0143-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)30437188</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV010092232</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC483</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.89/18</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 5800</subfield><subfield code="0">(DE-625)153018:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Clinical evaluation of psychotropic drugs</subfield><subfield code="b">principles and guidelines</subfield><subfield code="c">in assoc. with the NIMH ... Ed. Robert F. Prien</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">Raven Press</subfield><subfield code="c">1994</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XXI, 728 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Klinische geneeskunde</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Psychofarmaca</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical Trials as Topic</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Evaluation</subfield><subfield code="x">methods</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Mental Disorders</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Mental illness</subfield><subfield code="x">Chemotherapy</subfield><subfield code="x">Evaluation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Mental illness</subfield><subfield code="x">Chemotherapy</subfield><subfield code="x">Research</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Psychotropic Drugs</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Psychotropic drugs</subfield><subfield code="x">Testing</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Evaluation</subfield><subfield code="0">(DE-588)4071034-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Psychopharmakon</subfield><subfield code="0">(DE-588)4047729-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Psychopharmakon</subfield><subfield code="0">(DE-588)4047729-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Evaluation</subfield><subfield code="0">(DE-588)4071034-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Prien, Robert F.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">National Institute of Mental Health (USA)</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)8555-8</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006698610&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-006698610</subfield></datafield></record></collection> |
| id | DE-604.BV010092232 |
| illustrated | Not Illustrated |
| indexdate | 2025-02-03T16:34:53Z |
| institution | BVB |
| institution_GND | (DE-588)8555-8 |
| isbn | 0781701430 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-006698610 |
| oclc_num | 30437188 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-29 DE-20 DE-19 DE-BY-UBM DE-578 |
| owner_facet | DE-355 DE-BY-UBR DE-29 DE-20 DE-19 DE-BY-UBM DE-578 |
| physical | XXI, 728 S. |
| publishDate | 1994 |
| publishDateSearch | 1994 |
| publishDateSort | 1994 |
| publisher | Raven Press |
| record_format | marc |
| spellingShingle | Clinical evaluation of psychotropic drugs principles and guidelines Klinische geneeskunde gtt Psychofarmaca gtt Clinical Trials as Topic Drug Evaluation methods Mental Disorders drug therapy Mental illness Chemotherapy Evaluation Mental illness Chemotherapy Research Psychotropic Drugs Psychotropic drugs Testing Evaluation (DE-588)4071034-8 gnd Psychopharmakon (DE-588)4047729-0 gnd |
| subject_GND | (DE-588)4071034-8 (DE-588)4047729-0 |
| title | Clinical evaluation of psychotropic drugs principles and guidelines |
| title_auth | Clinical evaluation of psychotropic drugs principles and guidelines |
| title_exact_search | Clinical evaluation of psychotropic drugs principles and guidelines |
| title_full | Clinical evaluation of psychotropic drugs principles and guidelines in assoc. with the NIMH ... Ed. Robert F. Prien |
| title_fullStr | Clinical evaluation of psychotropic drugs principles and guidelines in assoc. with the NIMH ... Ed. Robert F. Prien |
| title_full_unstemmed | Clinical evaluation of psychotropic drugs principles and guidelines in assoc. with the NIMH ... Ed. Robert F. Prien |
| title_short | Clinical evaluation of psychotropic drugs |
| title_sort | clinical evaluation of psychotropic drugs principles and guidelines |
| title_sub | principles and guidelines |
| topic | Klinische geneeskunde gtt Psychofarmaca gtt Clinical Trials as Topic Drug Evaluation methods Mental Disorders drug therapy Mental illness Chemotherapy Evaluation Mental illness Chemotherapy Research Psychotropic Drugs Psychotropic drugs Testing Evaluation (DE-588)4071034-8 gnd Psychopharmakon (DE-588)4047729-0 gnd |
| topic_facet | Klinische geneeskunde Psychofarmaca Clinical Trials as Topic Drug Evaluation methods Mental Disorders drug therapy Mental illness Chemotherapy Evaluation Mental illness Chemotherapy Research Psychotropic Drugs Psychotropic drugs Testing Evaluation Psychopharmakon |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006698610&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT prienrobertf clinicalevaluationofpsychotropicdrugsprinciplesandguidelines AT nationalinstituteofmentalhealthusa clinicalevaluationofpsychotropicdrugsprinciplesandguidelines |